Visionary Education Technology (US:GV) Globenewswire·2025-12-30 20:09Core Insights - Visionary Holdings Inc. has announced significant corporate developments, including a new leadership team and a strategic shift towards the anti-aging high-end medical aesthetics sector [1][4]. Governance and Leadership - A new nine-member Board of Directors was elected during the Annual General Meeting on October 29, 2025, with Mr. Xiyong Hou as CEO, Mr. Jun Huang as Co-CEO, Mr. Robert Jay Lees as COO, and Ms. Katy Liu as CFO [2]. - Mr. William T. Chai has been elected as Chairman of the Board, and Mr. Donald M. Kealey serves as Vice Chairman [2]. Audit and Compliance - Assentsure PAC has been reappointed as the Company's auditor for the fiscal years 2025-2026 [3]. Strategic Transformation - Visionary Holdings has completed a strategic transformation focusing on anti-aging high-end medical aesthetics, with its traditional education business now a supplementary division [4]. - The Company is prioritizing global technology R&D and market expansion in this high-growth sector [4]. Key Partnerships - In September 2025, Visionary Holdings established two major partnerships: - A global R&D partnership with Jiangsu Yike Regenerative Medicine Technology Co., Ltd. to develop and market medical aesthetics products [5]. - A joint venture with Anhui Weikang Kangling Medical Technology Co., Ltd. to build an "Anti-Aging High-End Medical Aesthetics and Health Center" in Toronto, Canada [5]. Financial Reporting - The draft of the Annual Report for the fiscal year ended March 31, 2025, is complete and undergoing final internal review, with plans to file with the U.S. Securities and Exchange Commission by January 12, 2026 [6]. Company Vision - The CEO stated that the successful completion of the strategic pivot marks a new era for Visionary Holdings, positioning the Company for sustained growth and long-term value for shareholders [7].